GLP-1 agonist use was associated with moderate reduction in risk for GS, CME and (surprisingly) NAION, strong reduction for POAG and PACG and robust reduction for dry and wet AMD
The supplement also offers female-specific benefits thanks to the inclusion of L
FDA status and supplement regulations The FDA hasn't approved NAD+ or NR as standalone treatments [6]
A 10mg vial, 2mL of bacteriostatic water, a U-100 insulin syringe
That distinction shows up in practical ways: your GLP-1 workup can catch an undiagnosed thyroid problem or prediabetes that a weight-loss-only clinic would never screen for, your prescriber can see your full medication list including psychiatric medications in the same chart, and if a GLP-1 turns out not to be the right tool, the same visit can pivot to addressing what actually is driving the case, whether that is a sleep disorder, a mood disorder, or an untreated metabolic condition
second, by inhibiting GABA reuptake, it directly enhances network excitability (Barros-Barbosa et al., 2016)
